Trial Profile

A phase I, randomized, double-blind, single ascending dose study to evaluate the safety, tolerability, and pharmacokinetic profile of vesicular monoamine transporter 2 (VMAT2) inhibitor in healthy participants

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 11 Feb 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

05 Feb 2019 According to a Neurocrine Biosciences media release, the multiple dosing portion of the study is ongoing and is expected to be completed during the first half of 2019.
16 Nov 2018 New trial record
05 Nov 2018 According to a Neurocrine Biosciences media release, the study s anticipated to be completed during the fourth quarter of 2018.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com